Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Rabinowitz currently holds 138,043 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Rabinowitz has been a net seller of ORMP stock. They have purchased $0 and sold $167.2K worth of shares.
Michael Rabinowitz's most recent insider trade was on Jan 3, 2023, when they sold 1,425 shares at $13.01 per share.
Michael Rabinowitz serves as Executive at ORAMED PHARMACEUTICALS INC. (ORMP). They have executed 7 insider transactions totaling $167.2K over their tenure at the company.
Michael Rabinowitz holds the position of Executive at ORAMED PHARMACEUTICALS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michael Rabinowitz has shown a selling trading pattern, with $0 in total purchases and $167.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Rabinowitz was on Jan 3, 2023, when they sold $148.6K worth of ORMP shares. This transaction involved 11,900 shares at $12.49 per share.
Michael Rabinowitz currently owns 138,043 shares of ORAMED PHARMACEUTICALS INC. (ORMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Rabinowitz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Rabinowitz has 7 Form 4 filings on record as an insider at ORAMED PHARMACEUTICALS INC..
Set alerts for Michael Rabinowitz and 40,000+ other insiders.